Yoshihiro Miyata, Ryota Shibaki, Hiroaki Akamatsu, Mitsuo Osuga, Yasuhiro Koh, Kenta Murotani, Kazumi Nishino, Terufumi Kato, Kazushige Wakuda, Tetsuya Mitsudomi, Kenichi Yoshimura, Nobuyuki Yamamoto. "A phase II study of atezolizumab combined with cisplatin and vinorelbine as adjuvant therapy for completely resected non-small cell lung cancer with EGFR mutation (WJOG11719L: ADJUST study).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e20004